Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caribou Biosciences Inc
(NQ:
CRBU
)
2.210
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
838,164
Open
2.230
Bid (Size)
2.150 (1)
Ask (Size)
2.250 (12)
Prev. Close
2.210
Today's Range
2.175 - 2.255
52wk Range
1.500 - 8.330
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Caribou Biosciences to Participate in Upcoming Investor Conferences
Today 16:00 EDT
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
August 14, 2024
Via
Benzinga
Performance
YTD
-60.32%
-60.32%
1 Month
-6.36%
-6.36%
3 Month
-26.09%
-26.09%
6 Month
-70.22%
-70.22%
1 Year
-64.64%
-64.64%
More News
Read More
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
August 12, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Evaluating Caribou Biosciences: Insights From 4 Financial Analysts
July 17, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
June 04, 2024
Via
Benzinga
Expert Ratings For Caribou Biosciences
May 16, 2024
Via
Benzinga
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
July 09, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
June 03, 2024
Via
Benzinga
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
June 02, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
May 30, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Attention Biotech Investors - Stocks To Watch
May 16, 2024
Via
Benzinga
3 Underappreciated Stocks That Could 10x in 10 Years
May 12, 2024
Via
InvestorPlace
CRBU Stock Earnings: Caribou Biosciences Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 01, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 27, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
April 15, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
April 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
April 04, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points
March 13, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Gold Down Over 1%; ClearOne Shares Spike Higher
March 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 12, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.